Add categories

Browse categories and add by clicking on them

You can remove current categories below by clicking the ‘x’.

9 months ago

@wojtek , your English is fine.

In the UK, there are no options for treatments for Secondary Progressive MS (SPMS).

In Europe generally, use of Rituximab in Progressive MS is considered off-label and not allowed by the European Medicines Agency. However, it is actually used anyway.

Both Rituximab and Cladribine have been shown to give some slowdown to MS activity. So, it all depends on what you are able to access and at what cost, if any.

Join to reply to this post.

Become part of the community so you can chat, compare and learn from other MSers.